IM Cannabis (IMCC) Share-based Compensation (IS) (2020 - 2025)
IM Cannabis (IMCC) recorded quarterly Share-based Compensation (IS) of $1453.3 in Q3 2025, down 49.66% quarter-over-quarter from $2886.8 in Q2 2025, and down 99.19% on a YoY basis from $178865.0 in Q3 2024.
IM Cannabis (IMCC) Share-based Compensation (IS) (2020 - 2025) Analysis & Trends
IM Cannabis' Share-based Compensation (IS) history runs 6 years deep, the most recent figure standing at $1453.3 for Q3 2025.
- In Q3 2025, Share-based Compensation (IS) fell 99.19% year-over-year to $1453.3; the TTM figure through Dec 2025 stood at $9915.5 (down 96.33% YoY), while the FY2025 annual figure was $10039.2, down 96.28% from the prior year.
- Share-based Compensation (IS) was $1453.3 for Q3 2025 at IM Cannabis, down from $2886.8 in the prior quarter.
- In the past five years, Share-based Compensation (IS) ranged from a high of $2.1 million in Q3 2021 to a low of -$101990.0 in Q2 2023.
- Historically, Share-based Compensation (IS) has averaged $393330.4 across 5 years, with a median of $145456.4 in 2023.
- The sharpest annual moves came in 2022 and 2023: Share-based Compensation (IS) soared 68241.07% in 2022, then plunged 117.76% in 2023.
- A 5-year view of Share-based Compensation (IS) shows it stood at $1679.5 in 2021, then jumped by 68241.07% to $1.1 million in 2022, then tumbled by 105.82% to -$66842.7 in 2023, then surged by 105.35% to $3579.2 in 2024, then plunged by 59.4% to $1453.3 in 2025.
- The last three Share-based Compensation (IS) figures came in at $1453.3 (Q3 2025), $2886.8 (Q2 2025), and $5575.3 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | IM Cannabis | 57,090.22 | -728,264.31 | 1.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,453.27 |
| Sep 30, 2025 | 1,453.27 |
| Jun 30, 2025 | 2,886.85 |
| Jun 30, 2025 | 2,886.85 |
| Mar 31, 2025 | 5,575.33 |
| Mar 31, 2025 | 5,575.33 |
| Dec 31, 2024 | 3,579.25 |
| Dec 31, 2024 | 3,579.25 |
| Sep 30, 2024 | 178,865.03 |
| Sep 30, 2024 | 178,865.03 |
| Jun 30, 2024 | 64,340.37 |
| Jun 30, 2024 | 64,340.37 |
| Mar 31, 2024 | 23,747.62 |
| Mar 31, 2024 | 23,747.62 |
| Dec 31, 2023 | -66,842.73 |
| Dec 31, 2023 | -66,842.73 |
| Sep 30, 2023 | 145,456.44 |
| Sep 30, 2023 | 145,456.44 |
| Jun 30, 2023 | -101,989.99 |
| Jun 30, 2023 | -101,989.99 |